Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 5/2018

Open Access 05.02.2018 | Original Article

Characterization of the nasopharyngeal and middle ear microbiota in gastroesophageal reflux-prone versus gastroesophageal reflux non-prone children

verfasst von: Stefan A. Boers, Marjolein de Zeeuw, Ruud Jansen, Marc P. van der Schroeff, Annemarie M. C. van Rossum, John P. Hays, Suzanne J. C. Verhaegh

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 5/2018

Abstract

Otitis media (OM) is one of the most common pediatric infections worldwide, but the complex microbiology associated with OM is poorly understood. Previous studies have shown an association between OM and gastroesophageal reflux (GER) in children. Therefore, in order to bridge the gap in our current understanding of the interaction between GER and OM, we investigated the nasopharyngeal and middle ear microbiota of children suffering from GER-associated OM and OM only, using culture-independent 16S rRNA gene sequencing. Middle ear fluid, nasopharyngeal swabs, and clinical data were collected as part of a prospective pilot study conducted at the Department of Otorhinolaryngology of the Erasmus MC-Sophia Children’s Hospital, Rotterdam, the Netherlands. A total of 30 children up to 12 years of age who suffered from recurrent acute otitis media (AOM) (5), chronic otitis media with effusion (OME) (23), or both (2), and who were listed for tympanostomy tube placement, were included in the study. Nine children were included in the GER-associated OM cohort and 21 in the OM-only cohort. We found no obvious effect of GER on the nasopharyngeal and middle ear microbiota between the two groups of children. However, our results highlight the need to assess the true role of Alloiococcus spp. and Turicella spp. in children presenting with a high prevalence of recurrent AOM and chronic OME.

Introduction

Respiratory tract infections are the leading causes of morbidity and death in children and adults worldwide, with otitis media (OM) being one of the most prevalent pediatric respiratory tract infections [1]. OM causes severe pain and can lead to serious complications, such as meningitis, mastoiditis, and hearing loss. As an example, OM-related hearing impairment has a prevalence of 30.82 per 10,000, and, each year, 21,000 people die due to complications of OM (estimated from 21 World Health Organization [WHO] regional areas) [2]. Importantly, the pathogenesis of OM is multifactorial, involving genetic, microbiological, and environmental factors [3].
A potentially important, though relatively unknown, factor to be associated with OM is gastroesophageal reflux (GER). GER, also known as acid reflux, is a clinical manifestation in which the stomach’s contents return back up into the esophagus and mouth. Reflux is a normal process that occurs in healthy infants, children, and adults. Most episodes are brief and do not cause bothersome symptoms or complications. However, earlier studies have shown a strong association between GER and OM [46]. The mean prevalence of GER in children with (chronic) OM with effusion (OME) is 48% and in children with (recurrent) acute OM (AOM) 63%, while the mean prevalence of GER in healthy children is less than 10% [7]. The data suggest a role for GER in the multifactorial etiology of OM in children, a hypothesis strengthened by the detection of pepsin and bile acids in the middle ears of children presenting with OM [46], as well as the possible role of Helicobacter pylori in the etiology of OM [811]. However, to date, no one has used culture-independent techniques to investigate the possible influence of GER on the nasopharyngeal and middle ear microbiota in GER-prone children. In this respect, differences in the presence or absence of (specific) microorganisms in the middle ear of GER-prone versus GER non-prone children could help further establish a role for GER in the pathogenesis of OM.
Therefore, in order to bridge the gap in our current understanding of the interaction between GER and OM, we investigated the nasopharyngeal and middle ear microbiota of children suffering from GER-associated OM and OM only, using culture-independent 16S rRNA gene sequencing.

Materials and methods

Middle ear fluid (MEF), nasopharyngeal swabs (NPS), and clinical data were collected according to Klokkenburg et al. [4] and Stol et al. [12], as part of a prospective pilot study conducted at the Department of Otorhinolaryngology of the Erasmus MC-Sophia Children’s Hospital, Rotterdam, the Netherlands. Children with a history of craniofacial malformations/syndromes, or primary or acquired immune deficiency were excluded from participation. Questionnaires were used to obtain relevant patient characteristics from the parents of the GER-associated OM cohort and the OM-only cohort. The GER-associated cohort was defined via questionnaires based on the questions “Has your child been diagnosed with reflux in the previous three months?” and “Has your child been diagnosed with reflux in the past?” The study was approved by the Erasmus MC Medical Ethical Committee (MEC-2012-487). Written informed consent was obtained from parents or caregivers.
Microbiota profiles were analyzed using next-generation sequencing of hypervariable V5-V6 regions of the 16S rRNA gene, as previously described [13]. Prior to 16S rRNA gene sequencing, the total number of 16S rRNA gene copies within each DNA extraction was measured using a 16S quantitative polymerase chain reaction (PCR) according to Yang et al. [14]. This was performed in order to remove any specimens from the analysis where the contaminating bacterial DNA that is already present within chemicals and consumables used in the experimental procedure could be responsible for the results obtained. In this respect, all specimens that contained < 1000 16S rRNA gene copies/μL were not sequenced [15]. All sequence data obtained from specimens containing > 1000 16S rRNA gene copies/μL was processed using bioinformatics modules present in the mothur v.1.33.0 software package [16].
Statistical analyses were performed using IBM SPSS Statistics 21. Fisher’s exact test was used to calculate the statistical differences between patient baseline characteristics, differences between antibiotic use and specimen exclusion, antibiotic use, and pathogen detection, and to calculate the statistical differences of prominent middle ear microbiota between GER-prone and GER non-prone children. A p-value of ≤ 0.05 was considered to be statistically significant.
Data availability
The datasets generated and analyzed during the current study are available in the NCBI Sequence Read Archive (SRA) repository with the accession number SRP099862, https://​www.​ncbi.​nlm.​nih.​gov/​sra/​?​term=​SRP099862.

Results and discussion

16S rRNA gene sequencing

Thirty children up to 12 years of age who suffered from recurrent AOM (5), chronic OME (23), or both (2), and who were listed for tympanostomy tube placement, were included in the study (Table 1). Children were diagnosed based on the surgeon’s report.
Table 1
Demographic and clinical parameters stratified by the gastroesophageal reflux (GER)-associated otitis media (OM) cohort (n = 21) and the OM-only cohort (n = 9)
 
No GER, n = 21 (%)
GER, n = 9 (%)
p-Value
Demographic parameters
 Male sex
13 (61.9)
5 (55.6)
1
 Age, years
5.3 [1.3–6.0]
3.7 [0.8–12.8]
 
 Antibiotics ≤ 6 months preceding inclusion
12 (57.1)
5 (55.6)
1
 Siblings
16 (76.2)
5 (55.6)
0.39
 Day-care
7 (33.3)
7 (77.8)
0.05
 Smoking
14 (66.7)
5 (55.6)
0.69
 Breastfeeding
11 (52.4)
8 (88.9)
0.10
Diagnosis
 OME
16 (76.2)
7 (77.8)
1
 rAOM + (OME)
5 (23.8)
2 (22.2)
1
 Ventilation tube placement in past
11 (52.4)
1 (11.1)
0.05
 Adenotonsillectomy in past
7 (33.3)
0 (0)
0.07
In total, 11/30 MEF specimens and 11/30 NPS specimens (not, by definition, paired specimens) were excluded from 16S rRNA gene sequencing due to low DNA content (< 1000 16S rRNA gene copies/μL). Antibiotic use ≤ 6 months prior to inclusion in the study did not affect the exclusion of samples due to low DNA content (Table 2; MEF p = 0.13, NPS p = 0.45). The microbial composition of the remaining 38 specimens were sequenced and the data were processed using mothur. To reduce the effects of uneven sequencing depths, sequences were rarefied to 1000 sequences per specimen, which was sufficient to obtain a high degree of sequence coverage with an average Good’s coverage value of 0.98 (± 0.01).
Table 2
Inclusion and exclusion of samples related to antibiotic use ≤ 6 months preceding inclusion
 
MEF
p-Value
NPS
p-Value
Inclusion
Exclusion
Inclusion
Exclusion
Antibiotics
13
4
0.13
12
5
0.45
No antibiotics
6
7
7
6
Sequencing of the MEF microbiota resulted in the identification of 29 bacterial operational taxonomic units (OTUs) in 19 MEF specimens with an abundance > 1%, with an average of 4 OTUs (± 3) per specimen. Sequencing the nasopharyngeal microbiota identified 39 bacterial OTUs in 19 NPS specimens with > 1% abundance, with an average of 9 OTUs (± 4) per specimen.

Characterization of middle ear bacterial communities

The most commonly detected OTUs were Alloiococcus spp. and Turicella spp., present in 12 and 11 MEF specimens, respectively. There has been some debate as to whether members of the bacterial genera Alloiococcus and Turicella actually play a role in the pathogenesis of OM in children or if they are part of the commensal microbiota (and invading the middle ear following perforation) [1723]. Though A. otitidis and T. otitidis are frequently detected in OM children, it is questionable whether these organisms have enough pathogenic potential to induce OM, although studies have shown that A. otitidis may have enough immunogenic potential to modulate a host immune response [2426]. In addition, A. otitidis is able to form both single- and multispecies biofilms with Haemophilus influenzae. When present in polymicrobial biofilms, A. otitidis can promote H. influenzae growth and survival by increasing biofilm production in adverse growth conditions and by altering antimicrobial resistance [27]. In this study, the use of antibiotics ≤ 6 months prior to inclusion in the study did not have an effect on the detection of Alloiococcus spp., Haemophilus spp., Streptococcus spp., or Moraxella spp. (Table 3). These findings are clinically important, as antibiotics overuse or misuse can promote the development of bacterial resistance to antibiotics. Alloiococcus spp. and Turicella spp. were not detected by 16S rRNA gene sequencing in any nasopharyngeal swab. Previous PCR- and culture-based studies from other populations have reported A. otitidis in 7–12% of nasopharyngeal swabs, in contrast to the study of Marsh et al., who found no A. otitidis in paired nasopharyngeal swabs [17, 18, 28, 29]. Turicella otitidis is isolated almost exclusively from middle ear exudates [20, 23]. However, our study was limited to 30 children and it is possible that Alloiococcus spp. and Turicella spp. would have been detected in a larger cohort of children. Failure to detect Alloiococcus spp. and Turicella spp. in nasopharyngeal swabs from any of the children with positive ear MEF samples suggests that they are unlikely to be primary otopathogens in this population, since nasopharyngeal colonization is considered to be the antecedent of OM [30]. To better understand the potential role of Alloiococcus spp. and Turicella spp. in OM, further studies into host interactions and colonization of adjacent sites in healthy and diseased children will be necessary. Ultimately, the findings of this study will need to be further validated in the future with larger cohort sizes.
Table 3
Antibiotic use and pathogen detection in middle ear fluid (MEF)
Pathogen
No. of specimens
GER (n = 6)
p-Value
GER (n = 13)
p-Value
Without antibiotics (n = 2)
With antibiotics (n = 4)
Without antibiotics (n = 4)
With antibiotics (n = 9)
Alloiococcus spp.
2
0
0.07
3
7
1
Streptococcus spp.
0
1
1
1
4
1
Haemophilus spp.
1
1
1
1
6
0.27
Moraxella spp.
0
0
1
0
1
1
OTUs consistent with classical otopathogens such as Haemophilus spp., Streptococcus spp., and Moraxella spp. were detected in 9, 6, and 1 MEF specimens, respectively (Fig. 1). In addition, staphylococci were also found in the MEF of seven children, with an abundance up to 100%. Our findings are consistent with several other studies; for example, Haemophilus (influenzae) has been found to be the most common pathogen isolated in the context of widespread conjugate pneumococcal vaccination [31, 32]. Further, the presence of Haemophilus (influenzae) has been associated with an increased risk of OM, whereas the presence of Corynebacterium spp. and Dolosigranulum spp. have been associated with a decreased risk of OM [33, 34].
No upper gastrointestinal tract microbiota previously associated with OM (e.g., H. pylori) was detected in the middle ear. Further, we did not find any microbial difference in the MEF of children with or without GER (Table 4), suggesting that GER was not associated with the translocation of stomach microbiota to the middle ear in our cohort.
Table 4
Effect of GER on the presence of prominent middle ear microbiota
Pathogen
No. of specimens
GER (n = 6)
No GER (n = 13)
p-Value
Alloiococcus spp.
2
10
0.13
Haemophilus spp.
2
7
0.66
Streptococcus spp.
1
5
0.60
Moraxella spp.
0
1
1
To study the co-occurrence of OM-related pathogens in the nasopharynx and middle ear, we compared the microbiota obtained from 12 paired NPS and MEF specimens (Fig. 2). Nine OTUs were present in both specimen types, of which four OTUs, including Haemophilus spp., Streptococcus spp., Parvimonas spp., and Staphylococcus spp. were present in both paired specimen types from 10/12 children. Importantly, Haemophilus spp. and Streptococcus spp. were only detected in MEF when the nasopharynx of the child was concurrently colonized with these bacterial genera. This finding is in agreement with previous studies, and suggests that the more easily accessible nasopharyngeal microbiota could be used to predict the presence of pediatric otopathogens in the middle ears of children suffering from OM. However, it should be noted that the majority of OTUs, including the dominant genera Alloiococcus spp. and Turicella spp., were unique to the sampling site and, therefore, caution is necessary when using the nasopharyngeal microbiota as a proxy for the MEF microbiota, as discussed previously by van Dongen et al. [35].

Strengths and limitations of the study

The strength of this publication is that it is the first study to investigate the possible association between the microbial composition of the nasopharynx and middle ear in GER-prone and GER non-prone children using culture-free 16S rRNA gene sequencing. However, several limitations in the study protocol should be recognized.
Firstly, an actual diagnosis of GER is difficult to prove, as most cases of pediatric GER are diagnosed based solely on the clinical presentation and parental observation (and not, for example, on the presence of pepsin and bile acids in the middle ear). There are no recognized classic physical signs of GER in the pediatric population, and, in general, a doctor diagnoses GER by reviewing an infant’s symptoms and medical history. In this study, only parental-reported clinical information was collected. Essentially, we asked parents retrospectively if their child was diagnosed with reflux in the previous three months and if their child had been diagnosed with reflux at any time in the past. To date, the most thoroughly evaluated questionnaire for infant symptoms is the Infant Gastroesophageal Reflux Questionnaire Revised (I-GERQ-R) [36]. We designed our own questionnaire, as even an established questionnaire such as the I-GERQ-R was not validated to be adequately specific to differentiate GER infants from other symptomatic, but non-GER, infants, particularly if the treatments being tested are directed at acid reflux. For that purpose, additional inclusion criteria, such as esophageal pH monitoring or histology, are currently necessary to ensure adequate diagnostic specificity [36]. In the current study, we did not confirm the parental-reported diagnosis of GER by the identification of bile acids/pepsin in MEF or measurement of the MEF pH levels. These tools have proven to be useful for determining the presence of pathological GER [46]. The absence of these tools in our study may have influenced the fact that we found no statistically significant association between the microbiota profiles of GER-prone and GER non-prone children.
Secondly, our study included only children primarily diagnosed with OME, as these children are mainly listed for tympanostomy tube placement. Most children with AOM experience a self-limiting illness and lack the presence of fluid in the middle ear. Many will not present to a doctor. This means that an association between GER and AOM disease is much more difficult to prove than between GER and OME disease, but does not affect the hypothesis that GER may be associated with increased OM disease in GER-prone children.
Thirdly, as previously discussed, using the more easily accessible nasopharyngeal microbiota to predict the presence of pediatric otopathogens in the middle ears of children suffering from OME and AOM is questionable. Because of the size of the population studied and lack of data from other studies, data interpretation should be made with caution and regarded as preliminary. Further, we were unable to analyze the microbiota to the species level (a common problem with microbiota analysis [13]) and were, therefore, limited to bacterial taxonomic identification at the genus level.

Acknowledgements

The authors would like to thank the staff of the operating rooms of the Department of Otorhinolaryngology of the Erasmus MC-Sophia Children’s Hospital, the parents who consented, and the children who participated in this study.

Funding

None to declare.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study was approved by the Erasmus MC Medical Ethical Committee (MEC-2012-487).
Written informed consent was obtained from parents or caregivers.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Marchisio P, Bianchini S, Capaccio P, Esposito S, Fusi M, Nazzari E, Torretta S, Principi N (2010) Insights into infectious otitis media. Int J Immunopathol Pharmacol 23(1 Suppl):20–23PubMed Marchisio P, Bianchini S, Capaccio P, Esposito S, Fusi M, Nazzari E, Torretta S, Principi N (2010) Insights into infectious otitis media. Int J Immunopathol Pharmacol 23(1 Suppl):20–23PubMed
2.
Zurück zum Zitat Monasta L, Ronfani L, Marchetti F, Montico M, Vecchi Brumatti L, Bavcar A, Grasso D, Barbiero C, Tamburlini G (2012) Burden of disease caused by otitis media: systematic review and global estimates. PLoS One 7(4):e36226CrossRefPubMedPubMedCentral Monasta L, Ronfani L, Marchetti F, Montico M, Vecchi Brumatti L, Bavcar A, Grasso D, Barbiero C, Tamburlini G (2012) Burden of disease caused by otitis media: systematic review and global estimates. PLoS One 7(4):e36226CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM (2004) Otitis media. Lancet 363(9407):465–473CrossRefPubMed Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM (2004) Otitis media. Lancet 363(9407):465–473CrossRefPubMed
4.
Zurück zum Zitat Klokkenburg JJ, Hoeve HL, Francke J, Wieringa MH, Borgstein J, Feenstra L (2009) Bile acids identified in middle ear effusions of children with otitis media with effusion. Laryngoscope 119(2):396–400CrossRefPubMed Klokkenburg JJ, Hoeve HL, Francke J, Wieringa MH, Borgstein J, Feenstra L (2009) Bile acids identified in middle ear effusions of children with otitis media with effusion. Laryngoscope 119(2):396–400CrossRefPubMed
5.
Zurück zum Zitat He Z, O’Reilly RC, Bolling L, Soundar S, Shah M, Cook S, Schmidt RJ, Bloedon E, Mehta DI (2007) Detection of gastric pepsin in middle ear fluid of children with otitis media. Otolaryngol Head Neck Surg 137(1):59–64CrossRefPubMed He Z, O’Reilly RC, Bolling L, Soundar S, Shah M, Cook S, Schmidt RJ, Bloedon E, Mehta DI (2007) Detection of gastric pepsin in middle ear fluid of children with otitis media. Otolaryngol Head Neck Surg 137(1):59–64CrossRefPubMed
6.
Zurück zum Zitat He Z, O’Reilly RC, Mehta D (2008) Gastric pepsin in middle ear fluid of children with otitis media: clinical implications. Curr Allergy Asthma Rep 8(6):513–518CrossRefPubMed He Z, O’Reilly RC, Mehta D (2008) Gastric pepsin in middle ear fluid of children with otitis media: clinical implications. Curr Allergy Asthma Rep 8(6):513–518CrossRefPubMed
7.
Zurück zum Zitat Miura MS, Mascaro M, Rosenfeld RM (2012) Association between otitis media and gastroesophageal reflux: a systematic review. Otolaryngol Head Neck Surg 146(3):345–352CrossRefPubMed Miura MS, Mascaro M, Rosenfeld RM (2012) Association between otitis media and gastroesophageal reflux: a systematic review. Otolaryngol Head Neck Surg 146(3):345–352CrossRefPubMed
8.
Zurück zum Zitat Sudhoff H, Rajagopal S, Baguley DM, Ebmeyer J, Schmelzer A, Schreiber S, Moffat DA (2008) A critical evaluation of the evidence on a causal relationship between Helicobacter pylori and otitis media with effusion. J Laryngol Otol 122(9):905–911CrossRefPubMed Sudhoff H, Rajagopal S, Baguley DM, Ebmeyer J, Schmelzer A, Schreiber S, Moffat DA (2008) A critical evaluation of the evidence on a causal relationship between Helicobacter pylori and otitis media with effusion. J Laryngol Otol 122(9):905–911CrossRefPubMed
9.
Zurück zum Zitat Yılmaz MD, Aktepe O, Çetinkol Y, Altuntaş A (2005) Does Helicobacter pylori have role in development of otitis media with effusion? Int J Pediatr Otorhinolaryngol 69(6):745–749CrossRefPubMed Yılmaz MD, Aktepe O, Çetinkol Y, Altuntaş A (2005) Does Helicobacter pylori have role in development of otitis media with effusion? Int J Pediatr Otorhinolaryngol 69(6):745–749CrossRefPubMed
10.
Zurück zum Zitat Boronat-Echeverría N, Aguirre-Mariscal H, Carmolinga-Ponce M, Sevilla-Delgado Y, Miceli-Flores R, Kennedy-Padilla A, Mejía-Aranguré JM (2016) Helicobacter pylori detection and clinical symptomatology of gastroesophageal reflux disease in pediatric patients with otitis media with effusion. Int J Pediatr Otorhinolaryngol 87:126–129CrossRefPubMed Boronat-Echeverría N, Aguirre-Mariscal H, Carmolinga-Ponce M, Sevilla-Delgado Y, Miceli-Flores R, Kennedy-Padilla A, Mejía-Aranguré JM (2016) Helicobacter pylori detection and clinical symptomatology of gastroesophageal reflux disease in pediatric patients with otitis media with effusion. Int J Pediatr Otorhinolaryngol 87:126–129CrossRefPubMed
11.
Zurück zum Zitat Yılmaz T, Ceylan M, Akyön Y, Özçakýr O, Gürsel B (2006) Helicobacter pylori: a possible association with otitis media with effusion. Otolaryngol Head Neck Surg 134(5):772–777CrossRefPubMed Yılmaz T, Ceylan M, Akyön Y, Özçakýr O, Gürsel B (2006) Helicobacter pylori: a possible association with otitis media with effusion. Otolaryngol Head Neck Surg 134(5):772–777CrossRefPubMed
12.
Zurück zum Zitat Stol K, Verhaegh SJ, Graamans K, Engel JA, Sturm PD, Melchers WJ, Meis JF, Warris A, Hays JP, Hermans PW (2013) Microbial profiling does not differentiate between childhood recurrent acute otitis media and chronic otitis media with effusion. Int J Pediatr Otorhinolaryngol 77(4):488–493CrossRefPubMed Stol K, Verhaegh SJ, Graamans K, Engel JA, Sturm PD, Melchers WJ, Meis JF, Warris A, Hays JP, Hermans PW (2013) Microbial profiling does not differentiate between childhood recurrent acute otitis media and chronic otitis media with effusion. Int J Pediatr Otorhinolaryngol 77(4):488–493CrossRefPubMed
13.
Zurück zum Zitat Bogaert D, Keijser B, Huse S, Rossen J, Veenhoven R, van Gils E, Bruin J, Montijn R, Bonten M, Sanders E (2011) Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis. PLoS One 6(2):e17035CrossRefPubMedPubMedCentral Bogaert D, Keijser B, Huse S, Rossen J, Veenhoven R, van Gils E, Bruin J, Montijn R, Bonten M, Sanders E (2011) Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis. PLoS One 6(2):e17035CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Yang S, Lin S, Kelen GD, Quinn TC, Dick JD, Gaydos CA, Rothman RE (2002) Quantitative multiprobe PCR assay for simultaneous detection and identification to species level of bacterial pathogens. J Clin Microbiol 40(9):3449–3454CrossRefPubMedPubMedCentral Yang S, Lin S, Kelen GD, Quinn TC, Dick JD, Gaydos CA, Rothman RE (2002) Quantitative multiprobe PCR assay for simultaneous detection and identification to species level of bacterial pathogens. J Clin Microbiol 40(9):3449–3454CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Biesbroek G, Sanders EA, Roeselers G, Wang X, Caspers MP, Trzciński K, Bogaert D, Keijser BJ (2012) Deep sequencing analyses of low density microbial communities: working at the boundary of accurate microbiota detection. PLoS One 7(3):e32942CrossRefPubMedPubMedCentral Biesbroek G, Sanders EA, Roeselers G, Wang X, Caspers MP, Trzciński K, Bogaert D, Keijser BJ (2012) Deep sequencing analyses of low density microbial communities: working at the boundary of accurate microbiota detection. PLoS One 7(3):e32942CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF (2009) Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75(23):7537–7541CrossRefPubMedPubMedCentral Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF (2009) Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75(23):7537–7541CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Tano K, von Essen R, Eriksson PO, Sjöstedt A (2008) Alloiococcus otitidis—otitis media pathogen or normal bacterial flora? APMIS 116(9):785–790CrossRefPubMed Tano K, von Essen R, Eriksson PO, Sjöstedt A (2008) Alloiococcus otitidis—otitis media pathogen or normal bacterial flora? APMIS 116(9):785–790CrossRefPubMed
18.
Zurück zum Zitat Harimaya A, Takada R, Somekawa Y, Fujii N, Himi T (2006) High frequency of Alloiococcus otitidis in the nasopharynx and in the middle ear cavity of otitis-prone children. Int J Pediatr Otorhinolaryngol 70(6):1009–1014CrossRefPubMed Harimaya A, Takada R, Somekawa Y, Fujii N, Himi T (2006) High frequency of Alloiococcus otitidis in the nasopharynx and in the middle ear cavity of otitis-prone children. Int J Pediatr Otorhinolaryngol 70(6):1009–1014CrossRefPubMed
19.
Zurück zum Zitat Chan CL, Wabnitz D, Bardy JJ, Bassiouni A, Wormald PJ, Vreugde S, Psaltis AJ (2016) The microbiome of otitis media with effusion. Laryngoscope 126(12):2844–2851CrossRefPubMed Chan CL, Wabnitz D, Bardy JJ, Bassiouni A, Wormald PJ, Vreugde S, Psaltis AJ (2016) The microbiome of otitis media with effusion. Laryngoscope 126(12):2844–2851CrossRefPubMed
20.
Zurück zum Zitat Jervis-Bardy J, Rogers GB, Morris PS, Smith-Vaughan HC, Nosworthy E, Leong LE, Smith RJ, Weyrich LS, De Haan J, Carney AS, Leach AJ, O’Leary S, Marsh RL (2015) The microbiome of otitis media with effusion in Indigenous Australian children. Int J Pediatr Otorhinolaryngol 79(9):1548–1555CrossRefPubMed Jervis-Bardy J, Rogers GB, Morris PS, Smith-Vaughan HC, Nosworthy E, Leong LE, Smith RJ, Weyrich LS, De Haan J, Carney AS, Leach AJ, O’Leary S, Marsh RL (2015) The microbiome of otitis media with effusion in Indigenous Australian children. Int J Pediatr Otorhinolaryngol 79(9):1548–1555CrossRefPubMed
21.
Zurück zum Zitat Holzmann D, Funke G, Linder T, Nadal D (2002) Turicella otitidis and Corynebacterium auris do not cause otitis media with effusion in children. Pediatr Infect Dis J 21(12):1124–1126CrossRefPubMed Holzmann D, Funke G, Linder T, Nadal D (2002) Turicella otitidis and Corynebacterium auris do not cause otitis media with effusion in children. Pediatr Infect Dis J 21(12):1124–1126CrossRefPubMed
22.
Zurück zum Zitat von Graevenitz A, Funke G (2014) Turicella otitidis and Corynebacterium auris: 20 years on. Infection 42(1):1–4CrossRef von Graevenitz A, Funke G (2014) Turicella otitidis and Corynebacterium auris: 20 years on. Infection 42(1):1–4CrossRef
23.
Zurück zum Zitat Gomez-Garces JL, Alhambra A, Alos JI, Barrera B, García G (2004) Acute and chronic otitis media and Turicella otitidis: a controversial association. Clin Microbiol Infect 10(9):854–857CrossRefPubMed Gomez-Garces JL, Alhambra A, Alos JI, Barrera B, García G (2004) Acute and chronic otitis media and Turicella otitidis: a controversial association. Clin Microbiol Infect 10(9):854–857CrossRefPubMed
24.
Zurück zum Zitat Harimaya A, Takada R, Himi T, Yokota S, Fujii N (2007) Evidence of local antibody response against Alloiococcus otitidis in the middle ear cavity of children with otitis media. FEMS Immunol Med Microbiol 49(1):41–45CrossRefPubMed Harimaya A, Takada R, Himi T, Yokota S, Fujii N (2007) Evidence of local antibody response against Alloiococcus otitidis in the middle ear cavity of children with otitis media. FEMS Immunol Med Microbiol 49(1):41–45CrossRefPubMed
25.
Zurück zum Zitat Tarkkanen J, Himi T, Harimaya A, Carlson P, Ylikoski J, Mattila PS (2000) Stimulation of adenoidal lymphocytes by Alloiococcus otitidis. Ann Otol Rhinol Laryngol 109(10 Pt 1):958–964CrossRefPubMed Tarkkanen J, Himi T, Harimaya A, Carlson P, Ylikoski J, Mattila PS (2000) Stimulation of adenoidal lymphocytes by Alloiococcus otitidis. Ann Otol Rhinol Laryngol 109(10 Pt 1):958–964CrossRefPubMed
26.
Zurück zum Zitat Himi T, Kita H, Mitsuzawa H, Harimaya A, Tarkkanen J, Hendolin P, Ylikoski J, Fujii N (2000) Effect of Alloiococcus otitidis and three pathogens of otitis media in production of interleukin-12 by human monocyte cell line. FEMS Immunol Med Microbiol 29(2):101–106CrossRefPubMed Himi T, Kita H, Mitsuzawa H, Harimaya A, Tarkkanen J, Hendolin P, Ylikoski J, Fujii N (2000) Effect of Alloiococcus otitidis and three pathogens of otitis media in production of interleukin-12 by human monocyte cell line. FEMS Immunol Med Microbiol 29(2):101–106CrossRefPubMed
27.
Zurück zum Zitat Chan CL, Richter K, Wormald PJ, Psaltis AJ, Vreugde S (2017) Alloiococcus otitidis forms multispecies biofilm with Haemophilus influenzae: effects on antibiotic susceptibility and growth in adverse conditions. Front Cell Infect Microbiol 7:344CrossRefPubMedPubMedCentral Chan CL, Richter K, Wormald PJ, Psaltis AJ, Vreugde S (2017) Alloiococcus otitidis forms multispecies biofilm with Haemophilus influenzae: effects on antibiotic susceptibility and growth in adverse conditions. Front Cell Infect Microbiol 7:344CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Kaur R, Adlowitz DG, Casey JR, Zeng M, Pichichero ME (2010) Simultaneous assay for four bacterial species including Alloiococcus otitidis using multiplex-PCR in children with culture negative acute otitis media. Pediatr Infect Dis J 29(8):741–745CrossRefPubMedPubMedCentral Kaur R, Adlowitz DG, Casey JR, Zeng M, Pichichero ME (2010) Simultaneous assay for four bacterial species including Alloiococcus otitidis using multiplex-PCR in children with culture negative acute otitis media. Pediatr Infect Dis J 29(8):741–745CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Marsh RL, Binks MJ, Beissbarth J, Christensen P, Morris PS, Leach AJ, Smith-Vaughan HC (2012) Quantitative PCR of ear discharge from indigenous Australian children with acute otitis media with perforation supports a role for Alloiococcus otitidis as a secondary pathogen. BMC Ear Nose Throat Disord 12:11CrossRefPubMedPubMedCentral Marsh RL, Binks MJ, Beissbarth J, Christensen P, Morris PS, Leach AJ, Smith-Vaughan HC (2012) Quantitative PCR of ear discharge from indigenous Australian children with acute otitis media with perforation supports a role for Alloiococcus otitidis as a secondary pathogen. BMC Ear Nose Throat Disord 12:11CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Jervis-Bardy J, Carney AS, Duguid R, Leach AJ (2017) Microbiology of otitis media in Indigenous Australian children: review. J Laryngol Otol 131(S2):S2–S11CrossRefPubMed Jervis-Bardy J, Carney AS, Duguid R, Leach AJ (2017) Microbiology of otitis media in Indigenous Australian children: review. J Laryngol Otol 131(S2):S2–S11CrossRefPubMed
31.
Zurück zum Zitat Casey JR, Adlowitz DG, Pichichero ME (2010) New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 29(4):304–309PubMedPubMedCentral Casey JR, Adlowitz DG, Pichichero ME (2010) New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 29(4):304–309PubMedPubMedCentral
32.
Zurück zum Zitat Unger SA, Bogaert D (2017) The respiratory microbiome and respiratory infections. J Infect 74(Suppl 1):S84–S88CrossRefPubMed Unger SA, Bogaert D (2017) The respiratory microbiome and respiratory infections. J Infect 74(Suppl 1):S84–S88CrossRefPubMed
33.
Zurück zum Zitat Pettigrew MM, Laufer AS, Gent JF, Kong Y, Fennie KP, Metlay JP (2012) Upper respiratory tract microbial communities, acute otitis media pathogens, and antibiotic use in healthy and sick children. Appl Environ Microbiol 78(17):6262–6270CrossRefPubMedPubMedCentral Pettigrew MM, Laufer AS, Gent JF, Kong Y, Fennie KP, Metlay JP (2012) Upper respiratory tract microbial communities, acute otitis media pathogens, and antibiotic use in healthy and sick children. Appl Environ Microbiol 78(17):6262–6270CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Biesbroek G, Tsivtsivadze E, Sanders EA, Montijn R, Veenhoven RH, Keijser BJ, Bogaert D (2014) Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. Am J Respir Crit Care Med 190(11):1283–1292CrossRefPubMed Biesbroek G, Tsivtsivadze E, Sanders EA, Montijn R, Veenhoven RH, Keijser BJ, Bogaert D (2014) Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. Am J Respir Crit Care Med 190(11):1283–1292CrossRefPubMed
35.
Zurück zum Zitat van Dongen TM, van der Heijden GJ, van Zon A, Bogaert D, Sanders EA, Schilder AG (2013) Evaluation of concordance between the microorganisms detected in the nasopharynx and middle ear of children with otitis media. Pediatr Infect Dis J 32(5):549–552CrossRefPubMed van Dongen TM, van der Heijden GJ, van Zon A, Bogaert D, Sanders EA, Schilder AG (2013) Evaluation of concordance between the microorganisms detected in the nasopharynx and middle ear of children with otitis media. Pediatr Infect Dis J 32(5):549–552CrossRefPubMed
36.
Zurück zum Zitat Orenstein SR (2010) Symptoms and reflux in infants: Infant Gastroesophageal Reflux Questionnaire Revised (I-GERQ-R)—utility for symptom tracking and diagnosis. Curr Gastroenterol Rep 12(6):431–436CrossRefPubMed Orenstein SR (2010) Symptoms and reflux in infants: Infant Gastroesophageal Reflux Questionnaire Revised (I-GERQ-R)—utility for symptom tracking and diagnosis. Curr Gastroenterol Rep 12(6):431–436CrossRefPubMed
37.
Zurück zum Zitat Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504CrossRefPubMedPubMedCentral Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504CrossRefPubMedPubMedCentral
Metadaten
Titel
Characterization of the nasopharyngeal and middle ear microbiota in gastroesophageal reflux-prone versus gastroesophageal reflux non-prone children
verfasst von
Stefan A. Boers
Marjolein de Zeeuw
Ruud Jansen
Marc P. van der Schroeff
Annemarie M. C. van Rossum
John P. Hays
Suzanne J. C. Verhaegh
Publikationsdatum
05.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 5/2018
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-017-3178-2

Weitere Artikel der Ausgabe 5/2018

European Journal of Clinical Microbiology & Infectious Diseases 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.